Inhibitors of beta-secretase

본 발명은 하기 구조식으로 표시되는 화합물또는 이의 약학적으로 허용가능한 염에 관한 것이다. 약학적 조성물 및 상기 화합물의 사용 방법 또한 개시된다. The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also...

Full description

Saved in:
Bibliographic Details
Main Authors MORALESRAMOS ANGEL, DILLARD LAWRENCE W, ZHENG YAJUN, JIA LANQI, LEFTHERIS KATERINA, WU ZHONGREN, CLAREMON DAVID A, HEINE NIKLAS, YUAN JING, CACATIAN SALVACION, XU ZHENRONG, MCKEEVER BRIAN, SINGH SURESH, VENKATRAMAN SHANKAR, FUCHS KLAUS, WU GUOSHENG
Format Patent
LanguageEnglish
Korean
Published 20.11.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract 본 발명은 하기 구조식으로 표시되는 화합물또는 이의 약학적으로 허용가능한 염에 관한 것이다. 약학적 조성물 및 상기 화합물의 사용 방법 또한 개시된다. The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
AbstractList 본 발명은 하기 구조식으로 표시되는 화합물또는 이의 약학적으로 허용가능한 염에 관한 것이다. 약학적 조성물 및 상기 화합물의 사용 방법 또한 개시된다. The present invention is directed to a compound represented by the following structural formula or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
Author VENKATRAMAN SHANKAR
LEFTHERIS KATERINA
CLAREMON DAVID A
DILLARD LAWRENCE W
JIA LANQI
HEINE NIKLAS
SINGH SURESH
WU ZHONGREN
YUAN JING
FUCHS KLAUS
MORALESRAMOS ANGEL
MCKEEVER BRIAN
XU ZHENRONG
WU GUOSHENG
CACATIAN SALVACION
ZHENG YAJUN
Author_xml – fullname: MORALESRAMOS ANGEL
– fullname: DILLARD LAWRENCE W
– fullname: ZHENG YAJUN
– fullname: JIA LANQI
– fullname: LEFTHERIS KATERINA
– fullname: WU ZHONGREN
– fullname: CLAREMON DAVID A
– fullname: HEINE NIKLAS
– fullname: YUAN JING
– fullname: CACATIAN SALVACION
– fullname: XU ZHENRONG
– fullname: MCKEEVER BRIAN
– fullname: SINGH SURESH
– fullname: VENKATRAMAN SHANKAR
– fullname: FUCHS KLAUS
– fullname: WU GUOSHENG
BookMark eNrjYmDJy89L5WSQ8czLyEzKLMkvKlbIT1NISi1J1C1OTS4C0sWpPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7Uk3jvIyMDQ3MDQyNzAxMLRmDhVAAX_JlU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 베타세크리타아제 저해제
ExternalDocumentID KR20170127048A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20170127048A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20170127048A3
Notes Application Number: KR20177032350
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171120&DB=EPODOC&CC=KR&NR=20170127048A
ParticipantIDs epo_espacenet_KR20170127048A
PublicationCentury 2000
PublicationDate 20171120
PublicationDateYYYYMMDD 2017-11-20
PublicationDate_xml – month: 11
  year: 2017
  text: 20171120
  day: 20
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies VITAE PHARMACEUTICALS, INC
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
RelatedCompanies_xml – name: VITAE PHARMACEUTICALS, INC
– name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Score 3.076795
Snippet 본 발명은 하기 구조식으로 표시되는 화합물또는 이의 약학적으로 허용가능한 염에 관한 것이다. 약학적 조성물 및 상기 화합물의 사용 방법 또한 개시된다. The present invention is directed to a compound represented by the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Inhibitors of beta-secretase
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171120&DB=EPODOC&locale=&CC=KR&NR=20170127048A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTI2TklJMk3WNTBIsdA1MbUw07VItDDWTUkG9oZMDdIMk1NBu5F9_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0d2xoDmw-GKi5ONm6Bvi7-DurOTvbegep-QWB5cCzrCYWjswMrMCGtDkoP7iGOYH2pRQgVypuggxsAUDz8kqEGJiy84UZOJ1hd68JM3D4Qqe8gUxo7isWYZDxzMvITMoE3Y-jkJ-mkAR0oW4xqNlXAqyKRBmU3VxDnD10gdbEw30V7x2E7CZjMQYWYH8_VYJBIdUYmO9A55aZA6t6w6RkyzRgHy4xNdHEPMXcwCLJQJJBBp9JUvilpRm4QFzQdjojAxkGlpKi0lRZYL1akiQHDg4AmMl5ng
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTI2TklJMk3WNTBIsdA1MbUw07VItDDWTUkG9oZMDdIMk1NBu5F9_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0d2xoDmw-GKi5ONm6Bvi7-DurOTvbegep-QWB5cCzrCYWjswMrMBGtjkoP7iGOYH2pRQgVypuggxsAUDz8kqEGJiy84UZOJ1hd68JM3D4Qqe8gUxo7isWYZDxzMvITMoE3Y-jkJ-mkAR0oW4xqNlXAqyKRBmU3VxDnD10gdbEw30V7x2E7CZjMQYWYH8_VYJBIdUYmO9A55aZA6t6w6RkyzRgHy4xNdHEPMXcwCLJQJJBBp9JUvil5Rk4PUJ8feJ9PP28pRm4QFKgrXVGBjIMLCVFpamywDq2JEkOHDQAd7h8kQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibitors+of+beta-secretase&rft.inventor=MORALESRAMOS+ANGEL&rft.inventor=DILLARD+LAWRENCE+W&rft.inventor=ZHENG+YAJUN&rft.inventor=JIA+LANQI&rft.inventor=LEFTHERIS+KATERINA&rft.inventor=WU+ZHONGREN&rft.inventor=CLAREMON+DAVID+A&rft.inventor=HEINE+NIKLAS&rft.inventor=YUAN+JING&rft.inventor=CACATIAN+SALVACION&rft.inventor=XU+ZHENRONG&rft.inventor=MCKEEVER+BRIAN&rft.inventor=SINGH+SURESH&rft.inventor=VENKATRAMAN+SHANKAR&rft.inventor=FUCHS+KLAUS&rft.inventor=WU+GUOSHENG&rft.date=2017-11-20&rft.externalDBID=A&rft.externalDocID=KR20170127048A